Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q1 FY27 Earnings Presentation
46 slides from Zota Health Care's earnings presentation, Aug 13, 2026
Slide 1: Cover letter to NSE
August 13, 2026 To, The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: Investor Presentation Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requiremen
Slide 2: Investor Presentation Q1FY27
Zota Health Care Limited INVESTOR PRESENTATION Q1FY27
Slide 3: Safe Harbour
Safe Harbour This presentation has been prepared by the Zota Health Care Limited (the “Company”) only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer
Slide 4: Agenda
AGENDA Company Overview Business Overview Davaindia Domestic Operations Export Operations Financial Overview 3
Slide 5: Company Overview
neatnearenta, | NEP GENERIC PHARMACY. Company Overview
Slide 6: Zota Healthcare At a Glance
Zota Healthcare At a Glance Financial Highlights (FY26 - Consolidated) Revenue from Operations Zota Health Care Ltd., a Headquartered in Surat and Davaindia, launched in 2017, The strategic business model publicly listed company on employing dedicated is a retail generic pharmacy allows Davaindia to
Slide 7: Our Journey
Our Journey Strengthening Core And Pioneering Davaindia Setting Up Formulations 2017 2018 Export Business Introduced Davaindia, a private sector Achieved ₹10+ Cr in Export Sales; & 75+ generic pharmacy, via three pilot outlets Davaindia stores Foundational Steps In Domestic Marketing 2010 2011 2019
Slide 8: Management Profile
Management Profile Ketankumar Zota Moxesh Zota Sujit Paul Chairman And Managing Director Group Chief Executive Non-executive Director Officer Total Experience: 38+ Total Experience: 10+ Total Experience: 23+ • Holds a D-Pharmacy degree • Holds a Bachelor’s degree in pharmacy & • Featured on Times No
Slide 9: Company Structure
Company Structure Step down subsidiary Supplying products at ALP* Davaindia Zota Health Care Limited (Listed entity) (Davaindia Health Mart Limited) Procurement in listed entity FOFO Domestic Export COCO (Sales to FOFO# stores) (COCO# stores) FOFO Sales through COCO Sales through Zota Health Care Da
Slide 10: Business Overview
neatnearenta, | NEP GENERIC PHARMACY. Business Overview
Slide 11: Business Verticals
Business Verticals DAVAINDIA Revenue contribution (Q1FY27) • A Retail generic pharmacy chain providing quality generic medicines. Focuses only on private-label products in: 02Store variants 30% – 90% Everyday Herbal Group • Company Owned Company Operated Savings on medicines as Exports • Medicinal |
Slide 12: Case Study – Savings on Davaindia margins
Case Study – Savings on Davaindia margins Company marketed by > Indian Pharma MNC 1 Indian Pharma MNC 2 Davaindia Same Tablet with Significant savings Molecule Rosuvastatin 10mg Rosuvastatin 10mg Rosuvastatin 10mg same molecule in margins Generic Type Branded Generic Trade Generic Generic Margins Mu
Slide 13: neatnearenta, | NEP GENERIC PHARMACY.
neatnearenta, | NEP GENERIC PHARMACY. jj, davaindia’ GENERIC PHARMACY
Slide 14: Davaindia - Retail Pharmacy Chain data
Davaindia - Retail Pharmacy Chain data Revolutionizing the generic pharmacy industry with affordable, accessible, quality healthcare solutions through retail pharmacies’ chain. 2000+ 2,825* 1,855 970 SKUs Total no. COCO stores FOFO Stores of stores *As of 30th June 2026 • Launched in 2017, Davaindia
Slide 15: Davaindia - Operating Model
Davaindia - Operating Model Davaindia Health Mart Limited has Offers a cluster-based store 2,000+ SKUs with 70% medicinal Cloud-based software and AI- implemented a hyperlocal e-commerce model model, optimizing accessibility products and 30% OTC products, with based tools for real-time supply for on
Slide 16: Davaindia - Eliminating traditional supply chain
Davaindia - Eliminating traditional supply chain By sourcing directly from manufacturers and selling straight to consumers, traditional pharma supply chain is eliminated & the cost benefits are transferred to the consumer Average consumer price ~75% savings Doctors on Davaindia medicines as compared
Slide 17: Strengthening the Visibility
Strengthening the Visibility Mr. Mahendra Singh Dhoni & Mr. Suniel Shetty as Brand Ambassador of Davaindia 16
Slide 18: Davaindia – What are COCO Stores
Davaindia – What are COCO Stores COCO stores are modern walk-in stores providing a distinct contrast to traditional counter-based pharmacies enhancing customer satisfaction and loyalty. Company-Owned Company-Operated (COCO) Rapid Expansion The timeline for launching a new COCO store has been signifi
Slide 19: Davaindia - COCO Stores
Davaindia - COCO Stores States No. of Stores Company-Owned Company-Operated 1,855 West Bengal 570 Operational Uttar Pradesh Operated by wholly-owned 338 subsidiary 24 COCO stores Maharashtra Davaindia Health202 Mart Ltd 60 Delhi 99 70 91 Enhancing Store Kerala 97 99 Economics Haryana 91 13 Uttarakha
Slide 20: Davaindia COCO - KPI’s (1/2)
Davaindia COCO - KPI’s (1/2) No. of Stores* Quarterly Footfall in lakhs 1855 44.2 1656 39.8 1438 34.3 1207 29.6 986 23.0 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27 *As of 30th June 2026 19
Slide 21: Davaindia COCO - KPI’s (2/2)
Davaindia COCO - KPI’s (2/2) Quarterly GMV ₹ lakhs Avg. Wallet Spend ₹ 270 ₹ 262 ₹ 11,569 250 ₹ 235 ₹ 9,324 ₹ 231 ₹ 229 ₹ 231 230 ₹ 7,923 ₹ 6,780 210 ₹ 5,290 190 170 150 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27 20
Slide 22: Store Vintage-Wise SSG Trend
Store Vintage-Wise SSG Trend Opening Period: (FY2021- FY2024) Opening Period: (FY2024 - 2025) Opening Period: (FY2025 - 2026) No. of Stores: 234 No. of Stores: 617 No. of Stores: 803 ₹ In lakhs ₹ In lakhs ₹ In lakhs Quarterly GMV Quarterly GMV Quarterly GMV ₹ 4.13 ₹ 2.28 ₹ 1.61 ₹ 3.75 ₹ 3.74 ₹ 3.84
Slide 23: SSG Performance: Period Wise Analysis
SSG Performance: Period Wise Analysis GMV in ₹lakhs/Month Q1FY26 Q4FY26 Q1FY27 7.38 7.08 6.56 5.08 4.70 4.28 3.61 3.27 2.92 2.44 2.59 2.95 2.70 2.40 2.22 2.21 2.34 1.95 1.98 1.98 1.76 1.72 1.31 1.70 1.42 1.14 April 25 to Dec 25 12+ Months 15+ Months 18+ Months 21+ Months 24+ Months 30 to 39 Months 3
Slide 24: Davaindia – What are FOFO Stores
Davaindia – What are FOFO Stores Franchisee-Owned Franchisee-Operated Asset-light franchise model (FOFO) FOFO stores employ an asset-light franchise model, contributing to the scalability and accessibility of our product offerings. Smaller Store size FOFO stores are compact and over-the-counter form
Slide 25: Davaindia - FOFO Stores
Davaindia - FOFO Stores States No. of Stores Uttar Pradesh 202 West Bengal 200 Odisha 123 17 Madhya Pradesh 76 2 Gujarat 60 7 Maharashtra 41 14 Rajasthan 41 36 3 1 31 Haryana 36 Delhi 31 41 12 970 202 Bihar 27 27 Kerala 22 22 Tripura 22 60 76 10 200 Operational FOFO stores Jammu & Kashmir 17 1 Uttar
Slide 26: Davaindia FOFO - KPI’s (1/2)
Davaindia FOFO - KPI’s (1/2) No. of Stores Quarterly Footfall 15.8 15.3 970 14.2 893 923 13.9 848 12.4 759 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27 Q1 FY26 Q2 FY26 Q3FY26 Q4FY26 Q1FY27 *As of 30th June 2026 25
Slide 27: Davaindia FOFO - KPI’s (1/2)
Davaindia FOFO - KPI’s (1/2) Quarterly GMV ₹ lakhs Avg. Wallet Spend ₹ 309 ₹ 4,833 ₹ 306 ₹ 4,711 ₹ 4,249 ₹ 3,923 ₹ 299 ₹ 3,488 ₹ 281 ₹ 282 Q1 FY26 Q2 FY26 Q3FY26 Q4FY26 Q1FY27 Q1 FY26 Q2 FY26 Q3FY26 Q4FY26 Q1FY27 *As of 30th June 2026 26
Slide 28: OTC (Over-the-counter) products
OTC (Over-the-counter) products Strategic Acquisition as a Acquired 87.78% stake in the Everyday Herbal Group*, move towards backward licensed by the Khadi and Village Industrial Commission, a integration strategic move towards backward integration. OTC products make up ~30% of the stock keeping uni
Slide 29: OTC (Over-the-counter) products
OTC (Over-the-counter) products 28
Slide 30: Davaindia is Revolutionizing the Indian Healthcare Scenario
Davaindia is Revolutionizing the Indian Healthcare Scenario ₹45,706 lacs ~60 % Gross Merchandise Value Davaindia Gross Margin in COCO format in FY26 2,825 30-90 % Savings to consumers on Fast growing FOFO & Generic medicines COCO store network* *As of 30th June 2026 25-30 % Mature COCO Stores EBITDA
Slide 31: State-Wise Presence of Davaindia Across India
State-Wise Presence of Davaindia Across India (COCO & FOFO Models) States FOFO COCO Total West Bengal 200 570 770 Uttar Pradesh 202 338 540 Maharashtra 41 202 243 Delhi 31 99 130 Odisha 123 6 129 Haryana 36 91 127 Gujarat 60 60 120 Kerala 22 97 119 Rajasthan 41 68 109 Madhya Pradesh 76 31 107 Uttara
Slide 32: Davaindia Competitive Edge
Davaindia Competitive Edge The USP of Davaindia: Affordable, Trustworthy, and Innovative Pharmacy Solutions BENEFITS TO THE CUSTOMERS BENEFITS TO THE FRANCHISEES Medicines priced at low MRP thereby ensuring affordability for the masses Store operations and the supply chain efficiently managed by clo
Slide 33: Healthy Repeats
Healthy Repeats Total Average (in %) With a strong base of 80% repeat customers, Davaindia demonstrates a high level of customer satisfaction 80% and loyalty. Repeat Customers 12% New Customers 08% Lost Customers 32 32
Slide 34: Higher Chronic category share
Higher Chronic category share CATEGORY MIX FY25 CATEGORY MIX FY26 57% 60% 27% 27% 16% 13% Chronic OTC Other Chronic OTC Other Higher chronic share: A significant 60% of our revenue comes from chronic disease category, signalling high realization and retention rates, reflecting our crucial role in su
Slide 35: Supply Chain Management
Supply Chain Management • The Company has outsourced supply chain management to a third-party warehousing & logistics partner. • A state-of-art central warehousing & processing center has been built in Surat, in Phase 1. • Eventually the Company will replicate such infrastructure across different zo
Slide 36: Domestic Operations
Domestic Operations 35
Slide 37: Domestic Operations
Domestic Operations Marketing Value Chain: Domestic marketing has been the oldest business vertical for the FDF Manufacturers Company and has remained its mainstay in the past. Until 2017, WHO-GMP certified this vertical contributed most of the Company’s revenues. This manufacturing partners busines
Slide 38: Export Operations
Export Operations 37
Slide 39: Export Operations
Export Operations Dossiers Registered In Global Markets Our Exports business vertical, which started in 2010, serves 1. Benin 15. Sri Lanka clients in over 30 countries, mainly in the CIS, Latin America, 2. Bolivia 16. Swaziland Africa, and Asia. At its plant in Sachin, SEZ, the Company 3. Cambodia
Slide 40: Financial Overview
neatnearenta, | NEP GENERIC PHARMACY. Financial Overview
Slide 41: Management Commentary
Management Commentary “We are pleased to begin FY27 on a strong note, building on the strong execution delivered during FY26. During the previous year, we successfully achieved the key milestones we had guided for, including robust revenue growth, expansion of the Davaindia network, improved profita
Slide 42: Quarterly Revenue Segmentation
Quarterly Revenue Segmentation Business Verticals – Consolidated Revenue bifurcation Davaindia ₹ lakhs Domestic Operations ₹ lakhs Export Operations ₹ lakhs Everyday Herbal ₹ lakhs 1,920 14,342 649 13,148 1,791 624 1,507 443 7,563 801 664 574 Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q
Slide 43: Annually Financial Snapshot
Annually Financial Snapshot Davaindia ₹ lakhs Domestic Operations ₹ lakhs Export Operations ₹ lakhs 41,741 6,794 3,471 3,190 3,014 6,342 2,467 5,983 2,004 5,950 18,621 5,689 10,356 5,578 4,122 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 Davaindia has driven revenue gro
Slide 44: Business Vertical Performance (Consolidated)
Business Vertical Performance (Consolidated) ₹ in lakhs (Consolidated) Q1 FY27 Particulars Business Vertical Consolidated Davaindia Domestic Exports Everyday Others Revenue from Operation 14,342.33 1,790.67 573.51 649.42 4.30 17,360.23 Cost of Goods Sold 4,676.09 1,225.08 203.47 497.52 2.07 6,604.23
Slide 45: Profit & Loss Statement (Consolidated)
Profit & Loss Statement (Consolidated) Particulars Q1FY27 Q4FY26 Q1FY26 FY26 FY25 Export Sales (SEZ) 573.51 801.15 664.16 3,471.09 3,190.34 Davaindia Sales 14,342.33 13,147.71 7,562.90 41,741.47 18,621.42 Domestic Sales 1,790.67 1,919.70 1,506.87 6,794.29 6,341.50 Everyday Herbal Group 649.42 443.41
Slide 46: Thank You
Borcelle Clinic Health for all THANK YOU "ZOTA HOUSE", Bhagwan Siddesh Chawan - Ayyappa Complex, Navsari siddesh.chawan@in.ey.com State Highway, opp. GIDC Main Road, Surat, Gujarat 394210 Ajit Mishra - ajit.j.mishra@in.ey.com cszota@zotahealthcare.com www.zotahealthcare.com 45